| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period?
|
J Infect Dis
|
2011
|
5.02
|
|
2
|
Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: reanalysis of West African studies.
|
Lancet
|
2003
|
3.44
|
|
3
|
Prevalence of neutralizing antibodies to adenoviral serotypes 5 and 35 in the adult populations of The Gambia, South Africa, and the United States.
|
Clin Diagn Lab Immunol
|
2004
|
2.58
|
|
4
|
Effect of revaccination with BCG in early childhood on mortality: randomised trial in Guinea-Bissau.
|
BMJ
|
2010
|
2.52
|
|
5
|
Small randomized trial among low-birth-weight children receiving bacillus Calmette-Guérin vaccination at first health center contact.
|
Pediatr Infect Dis J
|
2012
|
2.46
|
|
6
|
Is HIV-2- induced AIDS different from HIV-1-associated AIDS? Data from a West African clinic.
|
AIDS
|
2007
|
2.24
|
|
7
|
Vitamin A supplementation and BCG vaccination at birth in low birthweight neonates: two by two factorial randomised controlled trial.
|
BMJ
|
2010
|
2.18
|
|
8
|
Influence of Mycobacterium bovis bacillus Calmette-Guérin on antibody and cytokine responses to human neonatal vaccination.
|
J Immunol
|
2002
|
1.98
|
|
9
|
An epidemiological study of RSV infection in the Gambia.
|
Bull World Health Organ
|
2002
|
1.97
|
|
10
|
Effect of 50,000 IU vitamin A given with BCG vaccine on mortality in infants in Guinea-Bissau: randomised placebo controlled trial.
|
BMJ
|
2008
|
1.91
|
|
11
|
Mature CD8(+) T lymphocyte response to viral infection during fetal life.
|
J Clin Invest
|
2003
|
1.85
|
|
12
|
The natural history of HIV-1 and HIV-2 infections in adults in Africa: a literature review.
|
Bull World Health Organ
|
2004
|
1.76
|
|
13
|
The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa.
|
Hepatology
|
2004
|
1.69
|
|
14
|
249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma.
|
Oncogene
|
2005
|
1.49
|
|
15
|
20 years into the Gambia Hepatitis Intervention Study: assessment of initial hypotheses and prospects for evaluation of protective effectiveness against liver cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
1.44
|
|
16
|
Delaying bacillus Calmette-Guérin vaccination from birth to 4 1/2 months of age reduces postvaccination Th1 and IL-17 responses but leads to comparable mycobacterial responses at 9 months of age.
|
J Immunol
|
2010
|
1.42
|
|
17
|
Antiretroviral treatment in resource-poor settings: public health research priorities.
|
Trop Med Int Health
|
2005
|
1.37
|
|
18
|
Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians.
|
Virol J
|
2010
|
1.29
|
|
19
|
Early diphtheria-tetanus-pertussis vaccination associated with higher female mortality and no difference in male mortality in a cohort of low birthweight children: an observational study within a randomised trial.
|
Arch Dis Child
|
2012
|
1.28
|
|
20
|
The effect of high-dose vitamin A supplementation administered with BCG vaccine at birth may be modified by subsequent DTP vaccination.
|
Vaccine
|
2009
|
1.28
|
|
21
|
Sex differences in the vaccine-specific and non-targeted effects of vaccines.
|
Vaccine
|
2011
|
1.27
|
|
22
|
Evaluation of the dried blood spot filter paper technology and five testing strategies of HIV-1 and HIV-2 infections in West Africa.
|
Scand J Infect Dis
|
2006
|
1.26
|
|
23
|
Cytomegalovirus infection in Gambian infants leads to profound CD8 T-cell differentiation.
|
J Virol
|
2007
|
1.26
|
|
24
|
Age-dependent maturation of Toll-like receptor-mediated cytokine responses in Gambian infants.
|
PLoS One
|
2011
|
1.22
|
|
25
|
Aflatoxin exposure and viral hepatitis in the etiology of liver cirrhosis in the Gambia, West Africa.
|
Environ Health Perspect
|
2008
|
1.22
|
|
26
|
Virological and immunological correlates of mother-to-child transmission of cytomegalovirus in The Gambia.
|
J Infect Dis
|
2008
|
1.15
|
|
27
|
A national DNA bank in The Gambia, West Africa, and genomic research in developing countries.
|
Nat Genet
|
2004
|
1.13
|
|
28
|
Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants.
|
J Clin Microbiol
|
2009
|
1.12
|
|
29
|
Effect of vitamin A supplementation on measles-specific antibody levels in Guinea-Bissau.
|
Lancet
|
2002
|
1.12
|
|
30
|
Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
1.12
|
|
31
|
Virological and immunological response to Combivir and emergence of drug resistance mutations in a cohort of HIV-2 patients in The Gambia.
|
AIDS
|
2006
|
1.10
|
|
32
|
Observational study of vaccine efficacy 24 years after the start of hepatitis B vaccination in two Gambian villages: no need for a booster dose.
|
PLoS One
|
2013
|
1.10
|
|
33
|
The effects of acute malaria on Epstein-Barr virus (EBV) load and EBV-specific T cell immunity in Gambian children.
|
J Infect Dis
|
2009
|
1.09
|
|
34
|
Effect of high-dose vitamin A supplementation on the immune response to Bacille Calmette-Guerin vaccine.
|
Am J Clin Nutr
|
2007
|
1.09
|
|
35
|
Low level viremia and high CD4% predict normal survival in a cohort of HIV type-2-infected villagers.
|
AIDS Res Hum Retroviruses
|
2002
|
1.07
|
|
36
|
Plasma viral load, CD4 cell percentage, HLA and survival of HIV-1, HIV-2, and dually infected Gambian patients.
|
AIDS
|
2003
|
1.07
|
|
37
|
Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection.
|
J Clin Invest
|
2007
|
1.06
|
|
38
|
Aetiological differences in demographical, clinical and pathological characteristics of hepatocellular carcinoma in The Gambia.
|
Liver Int
|
2010
|
1.05
|
|
39
|
The optimal age of measles immunisation in low-income countries: a secondary analysis of the assumptions underlying the current policy.
|
BMJ Open
|
2012
|
1.04
|
|
40
|
Predominant influence of environmental determinants on the persistence and avidity maturation of antibody responses to vaccines in infants.
|
J Infect Dis
|
2006
|
1.04
|
|
41
|
Sex-differential effect on infant mortality of oral polio vaccine administered with BCG at birth in Guinea-Bissau. A natural experiment.
|
PLoS One
|
2008
|
1.03
|
|
42
|
Maintenance of large subpopulations of differentiated CD8 T-cells two years after cytomegalovirus infection in Gambian infants.
|
PLoS One
|
2008
|
1.02
|
|
43
|
Survival of previously measles-vaccinated and measles-unvaccinated children in an emergency situation: an unplanned study.
|
Pediatr Infect Dis J
|
2003
|
1.01
|
|
44
|
Effects of antenatal and postnatal environments on CD4 T-cell responses to Mycobacterium bovis BCG in healthy infants in the Gambia.
|
Clin Vaccine Immunol
|
2008
|
1.01
|
|
45
|
Application of real-time PCR to quantify hepatitis B virus DNA in chronic carriers in The Gambia.
|
Virol J
|
2006
|
1.00
|
|
46
|
The tuberculin skin test (TST) is affected by recent BCG vaccination but not by exposure to non-tuberculosis mycobacteria (NTM) during early life.
|
PLoS One
|
2010
|
1.00
|
|
47
|
Undetectable plasma viral load predicts normal survival in HIV-2-infected people in a West African village.
|
Retrovirology
|
2010
|
1.00
|
|
48
|
Hepatitis B immunisation induces higher antibody and memory Th2 responses in new-borns than in adults.
|
Vaccine
|
2004
|
1.00
|
|
49
|
Direct relationship between virus load and systemic immune activation in HIV-2 infection.
|
J Infect Dis
|
2010
|
0.99
|
|
50
|
Variation in Toll-like receptor 4 and susceptibility to group A meningococcal meningitis in Gambian children.
|
Pediatr Infect Dis J
|
2003
|
0.99
|
|
51
|
Greater CD8+ TCR heterogeneity and functional flexibility in HIV-2 compared to HIV-1 infection.
|
J Immunol
|
2003
|
0.99
|
|
52
|
Two distinct epidemics: the rise of HIV-1 and decline of HIV-2 infection between 1990 and 2007 in rural Guinea-Bissau.
|
J Acquir Immune Defic Syndr
|
2010
|
0.99
|
|
53
|
Ser-249TP53 mutation in tumour and plasma DNA of hepatocellular carcinoma patients from a high incidence area in the Gambia, West Africa.
|
Int J Cancer
|
2004
|
0.98
|
|
54
|
A randomized trial of a standard dose of Edmonston-Zagreb measles vaccine given at 4.5 months of age: effect on total hospital admissions.
|
J Infect Dis
|
2014
|
0.98
|
|
55
|
Natural killer cell function is well preserved in asymptomatic human immunodeficiency virus type 2 (HIV-2) infection but similar to that of HIV-1 infection when CD4 T-cell counts fall.
|
J Virol
|
2006
|
0.97
|
|
56
|
Survival of HIV-1 and HIV-2 perinatally infected children in The Gambia.
|
AIDS
|
2003
|
0.96
|
|
57
|
Effects of cryopreservation on CD4+ CD25+ T cells of HIV-1 infected individuals.
|
J Clin Lab Anal
|
2008
|
0.95
|
|
58
|
Cytomegalovirus infection induces T-cell differentiation without impairing antigen-specific responses in Gambian infants.
|
Immunology
|
2008
|
0.95
|
|
59
|
HIV-2 capsids distinguish high and low virus load patients in a West African community cohort.
|
Vaccine
|
2010
|
0.95
|
|
60
|
The effect of placental malaria infection on cord blood and maternal immunoregulatory responses at birth.
|
Eur J Immunol
|
2010
|
0.95
|
|
61
|
No differences in cellular immune responses between asymptomatic HIV type 1- and type 2-infected Gambian patients.
|
J Infect Dis
|
2004
|
0.95
|
|
62
|
Potent autologous and heterologous neutralizing antibody responses occur in HIV-2 infection across a broad range of infection outcomes.
|
J Virol
|
2011
|
0.93
|
|
63
|
A Gambian infant with fever and an unexpected blood film.
|
PLoS Med
|
2006
|
0.92
|
|
64
|
Oral polio vaccine influences the immune response to BCG vaccination. A natural experiment.
|
PLoS One
|
2010
|
0.92
|
|
65
|
Seasonal variation in TP53 R249S-mutated serum DNA with aflatoxin exposure and hepatitis B virus infection.
|
Environ Health Perspect
|
2011
|
0.91
|
|
66
|
Autoreactivity against induced or upregulated abundant self-peptides in HLA-A*0201 following measles virus infection.
|
Hum Immunol
|
2003
|
0.90
|
|
67
|
Quantification of Human T-lymphotropic virus type I (HTLV-I) provirus load in a rural West African population: no enhancement of human immunodeficiency virus type 2 pathogenesis, but HTLV-I provirus load relates to mortality.
|
J Infect Dis
|
2003
|
0.90
|
|
68
|
Partially randomized, non-blinded trial of DNA and MVA therapeutic vaccines based on hepatitis B virus surface protein for chronic HBV infection.
|
PLoS One
|
2011
|
0.90
|
|
69
|
CD8+ T cell responses to human immunodeficiency viruses type 2 (HIV-2) and type 1 (HIV-1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype.
|
Eur J Immunol
|
2005
|
0.89
|
|
70
|
No observed effect of GB virus C coinfection on disease progression in a cohort of African woman infected with HIV-1 or HIV-2.
|
Clin Infect Dis
|
2005
|
0.89
|
|
71
|
Correlates of T-cell-mediated viral control and phenotype of CD8(+) T cells in HIV-2, a naturally contained human retroviral infection.
|
Blood
|
2013
|
0.89
|
|
72
|
HTLV-1 in rural Guinea-Bissau: prevalence, incidence and a continued association with HIV between 1990 and 2007.
|
Retrovirology
|
2010
|
0.89
|
|
73
|
Development and evaluation of an oligonucleotide ligation assay for detection of drug resistance-associated mutations in the human immunodeficiency virus type 2 pol gene.
|
J Clin Microbiol
|
2007
|
0.89
|
|
74
|
Vaccine programmes must consider their effect on general resistance.
|
BMJ
|
2012
|
0.89
|
|
75
|
Population dynamics of HIV-2 in rural West Africa: comparison with HIV-1 and ongoing transmission at the heart of the epidemic.
|
AIDS
|
2013
|
0.88
|
|
76
|
Mycobacterial T cell responses in HIV-infected patients with advanced immunosuppression.
|
J Infect Dis
|
2008
|
0.88
|
|
77
|
CD4(+) T cell responses to cytomegalovirus in early life: a prospective birth cohort study.
|
J Infect Dis
|
2008
|
0.87
|
|
78
|
Sex differences in the effect of vaccines on the risk of hospitalization due to measles in Guinea-bissau.
|
Pediatr Infect Dis J
|
2010
|
0.87
|
|
79
|
Immunological predictors of survival in HIV type 2-infected rural villagers in Guinea-Bissau.
|
AIDS Res Hum Retroviruses
|
2005
|
0.86
|
|
80
|
Comprehensive analysis of HIV Gag-specific IFN-gamma response in HIV-1- and HIV-2-infected asymptomatic patients from a clinical cohort in The Gambia.
|
Eur J Immunol
|
2008
|
0.86
|
|
81
|
Epstein-Barr virus but not cytomegalovirus is associated with reduced vaccine antibody responses in Gambian infants.
|
PLoS One
|
2010
|
0.86
|
|
82
|
HTLV-1 and HIV-2 infection are associated with increased mortality in a rural West African community.
|
PLoS One
|
2011
|
0.85
|
|
83
|
Girls may have lower levels of maternal measles antibodies and higher risk of subclinical measles infection before the age of measles vaccination.
|
Vaccine
|
2009
|
0.84
|
|
84
|
Vaccinia scars associated with improved survival among adults in rural Guinea-Bissau.
|
PLoS One
|
2006
|
0.84
|
|
85
|
Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa.
|
BMC Res Notes
|
2011
|
0.84
|
|
86
|
Are plasma biomarkers of immune activation predictive of HIV progression: a longitudinal comparison and analyses in HIV-1 and HIV-2 infections?
|
PLoS One
|
2012
|
0.84
|
|
87
|
The effect of high-dose vitamin A supplementation given with bacille Calmette-Guérin vaccine at birth on infant rotavirus infection and diarrhea: a randomized prospective study from Guinea-Bissau.
|
J Infect Dis
|
2010
|
0.83
|
|
88
|
Increased prevalence of HTLV-1 among HIV-2-infected women but not HIV-2-infected men in rural Guinea-Bissau.
|
J Acquir Immune Defic Syndr
|
2002
|
0.83
|
|
89
|
Placental malaria is associated with attenuated CD4 T-cell responses to tuberculin PPD 12 months after BCG vaccination.
|
BMC Infect Dis
|
2012
|
0.83
|
|
90
|
Immunological impact of an additional early measles vaccine in Gambian children: responses to a boost at 3 years.
|
Vaccine
|
2012
|
0.82
|
|
91
|
Development, evaluation, and validation of an oligonucleotide probe hybridization assay to subtype human immunodeficiency virus type 1 circulating recombinant form CRF02_AG.
|
J Clin Microbiol
|
2004
|
0.82
|
|
92
|
Risk factors for measles in young infants in an urban African area with high measles vaccination coverage.
|
Pediatr Infect Dis J
|
2011
|
0.82
|
|
93
|
Downregulation of the T-cell receptor by human immunodeficiency virus type 2 Nef does not protect against disease progression.
|
J Virol
|
2009
|
0.81
|
|
94
|
Envelope protein variability among HBV-Infected asymptomatic carriers and immunized children with breakthrough infections.
|
J Med Virol
|
2008
|
0.81
|
|
95
|
Placental malaria is associated with reduced early life weight development of affected children independent of low birth weight.
|
Malar J
|
2010
|
0.81
|
|
96
|
The immunological effect of revaccination with Bacille Calmette-Guérin vaccine at 19 months of age.
|
Vaccine
|
2013
|
0.81
|
|
97
|
Presence of a multidrug-resistance mutation in an HIV-2 variant infecting a treatment-naive individual in Caio, Guinea Bissau.
|
Clin Infect Dis
|
2009
|
0.80
|
|
98
|
Molecular epidemiology of endemic human T-lymphotropic virus type 1 in a rural community in Guinea-Bissau.
|
PLoS Negl Trop Dis
|
2012
|
0.80
|
|
99
|
Low mortality after mild measles infection compared to uninfected children in rural West Africa.
|
Vaccine
|
2002
|
0.80
|
|
100
|
Highly avid, oligoclonal, early-differentiated antigen-specific CD8+ T cells in chronic HIV-2 infection.
|
Eur J Immunol
|
2010
|
0.79
|
|
101
|
Immune reconstitution inflammatory syndrome and the influence of T regulatory cells: a cohort study in The Gambia.
|
PLoS One
|
2012
|
0.79
|
|
102
|
Revisiting the effect of acute P. falciparum malaria on Epstein-Barr virus: host balance in the setting of reduced malaria endemicity.
|
PLoS One
|
2012
|
0.78
|
|
103
|
Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9 months or at 9 and 18 months of age: a serological study within a randomised trial of different measles vaccines.
|
Vaccine
|
2013
|
0.78
|
|
104
|
Cause of death among people with retroviral infection in rural Guinea-Bissau.
|
Trop Doct
|
2010
|
0.77
|
|
105
|
Maternal proviral load and vertical transmission of human T cell lymphotropic virus type 1 in Guinea-Bissau.
|
AIDS Res Hum Retroviruses
|
2012
|
0.77
|
|
106
|
High-titre measles vaccine and female mortality.
|
Lancet
|
2003
|
0.77
|
|
107
|
Is HIV-2-induced AIDS different from HIV-1-associated AIDS?
|
AIDS
|
2008
|
0.77
|
|
108
|
High-titer measles vaccination before 9 months of age and increased female mortality: do we have an explanation?
|
Semin Pediatr Infect Dis
|
2003
|
0.77
|
|
109
|
HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form.
|
Retrovirology
|
2010
|
0.77
|
|
110
|
Effect of HIV-2 infection on HIV-1 disease progression.
|
N Engl J Med
|
2012
|
0.76
|
|
111
|
Assuring trial safety for children.
|
Lancet
|
2008
|
0.75
|
|
112
|
The new decade of vaccines.
|
Lancet
|
2012
|
0.75
|
|
113
|
Quantitative association tests of immune responses to antigens of Mycobacterium tuberculosis: a study of twins in West Africa.
|
Twin Res
|
2004
|
0.75
|
|
114
|
No evidence of bias in trial showing BCG reduces neonatal mortality.
|
J Infect Dis
|
2011
|
0.75
|
|
115
|
Predicting the extinction of HIV-2 in rural Guinea-Bissau.
|
AIDS
|
2015
|
0.75
|
|
116
|
Declining trend of serological syphilis among genitourinary medicine patients in the Gambia, West Africa.
|
Sex Transm Dis
|
2009
|
0.75
|